ODDB.org: Open Drug Database

Labatec Pharma SA - Letrozol Labatec 2.5 mg, comprimés pelliculés

Swissmedic Registration	65164	Sequence	01
Product name	Letrozol Labatec 2.5 mg	Description	comprimés pelliculés
ATC-Classification	L02BG04	ATC-Description	Letrozole
Introduction of Sequence	24.06.2014

Composition

letrozolum 2.5 mg, cellulosum microcristallinum silicificatum, carboxymethylamylum natricum A, magnesii stearas, pellicule: poly(alcohol vinylicus), macrogolum 3350, talcum, E 171, E 172 (flavum), E 110 0.016 mg, pro compresso obducto corresp. natrium 0.212 mg.

Packungsbestandteile

Galenic Form

Coated tablets

Active Agent	Dose
Letrozol	2.5 mg

BAG: Active Agent	Dose
Letrozol	2.5 mg

Inactive agents	Dose	additional_information
(Flavum)
Carboxymethylamylum Natricum A
Cellulosum Microcristallinum Silicificatum
E 110	0.016 mg	color.
E 171		color.
E 172		color.
Macrogol	3350
Magnesii Stearas
Poly(Alcohol Vinylicus)		pellicule
Pro Compresso Obducto
Talcum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001	30 Tablet(s)	54.88	79.50	B	SL	Yes
002	100 Tablet(s)	182.09	225.65	B	SL	Yes

2024	©ywesee GmbH